Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis: Osaka, Japan Thursday, October 1, 2 ...
Five years ago, the approval of dapagliflozin for chronic kidney disease (CKD) by the US FDA marked a pivotal shift in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results